Cargando…
Improving patient informed consent for haemophilia gene therapy: the case for change
Adeno-associated virus-based gene therapy points to a coming transformation in the treatment of people living with haemophilia, promising sustained bleed control and potential improvement in quality of life. Nevertheless, the consequences of introducing new genetic material are not trivial. The perc...
Autores principales: | Woollard, Laurence, Gorman, Richard, Rosenfelt, Dakota J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032461/ https://www.ncbi.nlm.nih.gov/pubmed/37181114 http://dx.doi.org/10.1177/26330040211047244 |
Ejemplares similares
-
Gene therapy for haemophilia
por: Murphy, Samuel L, et al.
Publicado: (2008) -
Implications of haemophilia gene therapy for the changing role of the multidisciplinary team
por: Miesbach, Wolfgang, et al.
Publicado: (2021) -
Gene therapy in haemophilia: literature review and regional perspectives for Turkey
por: Kavaklı, Kaan, et al.
Publicado: (2022) -
How to discuss gene therapy for haemophilia? A patient and physician perspective
por: Miesbach, Wolfgang, et al.
Publicado: (2019) -
Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines
por: Petkovic, Madison J., et al.
Publicado: (2022)